First-pass extracted concept

programmable spatiotemporal control of CRISPR-Cas12a

Candidate: concept label1 source documents4 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This concept refers to engineering Cas12a so its activity can be restricted in time or space rather than occurring immediately after target engagement. The abstract frames this as a precision-enabling layer for editing and diagnostics.

Source 1DOI PubMed

Resources required

The abstract indicates that implementation depends on specific control modalities such as photocaged repeat-recognition-sequence designs, split-crRNA architectures, chemically inducible systems, or kinetic optimization approaches.

Source 1DOI PubMed

What problem it solves

It addresses the lack of intrinsic temporal or spatial restriction in Cas12a, which the abstract links to off-target effects, systemic exposure, and loss of tissue specificity.

Source 1DOI PubMed

What it does not solve

The abstract does not claim that spatiotemporal control alone solves all safety or performance limitations of Cas12a, and it notes remaining challenges and opportunities.

Source 1DOI PubMed

Alternatives

The abstract contrasts this controlled-use framing with unmodified Cas12a that is typically activated immediately upon target engagement.

Source 1DOI PubMed

Evidence Snippets

Consequently, strategies that enable precise spatiotemporal control of Cas12a activity are increasingly important.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application benefitsupports2026Source 1DOI PubMed

In diagnostic settings, temporal gating enhances signal fidelity by reducing background and false-positive readouts.

Quoted textsource-backed

In diagnostic settings, temporal gating enhances signal fidelity by reducing background and false-positive readouts

Claim 2application benefitsupports2026Source 1DOI PubMed

In therapeutic applications, controlled Cas12a activation may enable tissue-restricted editing and safer, reversible gene regulation.

Quoted textsource-backed

while in therapeutic applications, controlled activation may enable tissue-restricted editing and safer, reversible gene regulation.

Claim 3comparative featuresupports2026Source 1DOI PubMed

CRISPR-Cas12a is presented as a versatile alternative to Cas9 with thymine-rich PAM recognition, staggered 5' DNA breaks, simplified guide RNA architecture, and collateral single-stranded DNA cleavage.

Quoted textsource-backed

CRISPR-Cas12a has emerged as a versatile alternative to Cas9, offering distinct advantages, such as recognition of thymine-rich protospacer adjacent motifs, generation of staggered 5' DNA breaks, simplified guide RNA architecture, and collateral (trans) single-stranded DNA cleavage.

Claim 4limitationsupports2026Source 1DOI PubMed

Cas12a is typically activated immediately upon target engagement and may lack intrinsic mechanisms for restricting activity in time or space, which can increase off-target effects, systemic exposure, and loss of tissue specificity in some contexts.

Quoted textsource-backed

However, Cas12a is typically activated immediately upon target engagement and may lack intrinsic mechanisms for restricting activity in time or space, which can increase off-target effects, systemic exposure, and loss of tissue specificity in certain contexts.